These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 380343

  • 1. Peripheral steroid-gonadotropin interactions and diagnostic significance of double-stimulation tests with luteinizing hormone-releasing hormone in polycystic ovarian disease.
    Moltz L, Römmler A, Schwartz U, Bidlingmaier F, Hammerstein J.
    Am J Obstet Gynecol; 1979 Aug 01; 134(7):813-8. PubMed ID: 380343
    [No Abstract] [Full Text] [Related]

  • 2. Circulating gonadotropins, estrogens, and androgens in polycystic ovarian disease.
    DeVane GW, Czekala NM, Judd HL, Yen SS.
    Am J Obstet Gynecol; 1975 Feb 15; 121(4):496-500. PubMed ID: 125040
    [Abstract] [Full Text] [Related]

  • 3. Age variation of the 24-hour mean plasma concentrations of androgens, estrogens, and gonadotropins in normal adult men.
    Zumoff B, Strain GW, Kream J, O'Connor J, Rosenfeld RS, Levin J, Fukushima DK.
    J Clin Endocrinol Metab; 1982 Mar 15; 54(3):534-8. PubMed ID: 6799539
    [Abstract] [Full Text] [Related]

  • 4. Recovery of hormone secretion after chronic gonadotropin-releasing hormone agonist administration in women with polycystic ovarian disease.
    de Ziegler D, Steingold K, Cedars M, Lu JK, Meldrum DR, Judd HL, Chang RJ.
    J Clin Endocrinol Metab; 1989 Jun 15; 68(6):1111-7. PubMed ID: 2524501
    [Abstract] [Full Text] [Related]

  • 5. Dynamics of plasma gonadotropin and sex steroid release in polycystic ovarian disease after pituitary-ovarian inhibition with an analog of gonadotropin-releasing hormone.
    Calogero AE, Macchi M, Montanini V, Mongioi A, Maugeri G, Vicari E, Coniglione F, Sipione C, D'Agata R.
    J Clin Endocrinol Metab; 1987 May 15; 64(5):980-5. PubMed ID: 3104389
    [Abstract] [Full Text] [Related]

  • 6. The relation of hormone discriminants in plasma and breast cancer.
    Hill P, Wynder E, Helman P, Hickman R.
    Ann Clin Lab Sci; 1974 May 15; 4(5):350-6. PubMed ID: 4277719
    [No Abstract] [Full Text] [Related]

  • 7. Circulating hormone levels in a case of granulosa cell tumor.
    Wentz AC, McCranie WM.
    Fertil Steril; 1976 Feb 15; 27(2):167-70. PubMed ID: 765165
    [Abstract] [Full Text] [Related]

  • 8. [Endocrine effects of laser vaporization of the ovaries in women with polycystic ovary syndrome].
    Rossmanith WG, Keckstein J, Spatzier K, Lauritzen C.
    Gynakol Rundsch; 1991 Feb 15; 31 Suppl 2():333-5. PubMed ID: 1790971
    [No Abstract] [Full Text] [Related]

  • 9. Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome.
    Rebar R, Judd HL, Yen SS, Rakoff J, Vandenberg G, Naftolin F.
    J Clin Invest; 1976 May 15; 57(5):1320-9. PubMed ID: 770505
    [Abstract] [Full Text] [Related]

  • 10. Effect of gonadotrophin-releasing hormone analogue (GnRH-A) administration on serum gonadotrophin and steroid levels in patients with polycystic ovarian disease.
    Mongioi A, Maugeri G, Macchi M, Calogero A, Vicari E, Coniglione F, Aliffi A, Sipione C, D'Agata R.
    Acta Endocrinol (Copenh); 1986 Feb 15; 111(2):228-34. PubMed ID: 3082098
    [Abstract] [Full Text] [Related]

  • 11. Studies on the influence of ovarian small cysts on endocrine in patients with polycystic ovaries.
    Takahashi K, Uchida A, Yamasaki H, Ozaki T, Yoshino K, Kitao M.
    Gynecol Obstet Invest; 1994 Feb 15; 38(2):117-21. PubMed ID: 7959338
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Serum bioactive and immunoreactive luteinizing hormone and follicle-stimulating hormone levels in women with cycle abnormalities, with or without polycystic ovarian disease.
    Fauser BC, Pache TD, Lamberts SW, Hop WC, de Jong FH, Dahl KD.
    J Clin Endocrinol Metab; 1991 Oct 15; 73(4):811-7. PubMed ID: 1909705
    [Abstract] [Full Text] [Related]

  • 14. Pituitary and ovarian responses to LHRH stimulation in women with clinical features of the polycystic ovary syndrome.
    Heineman MJ, Thomas CM, Doesburg WH, Rolland R.
    Eur J Obstet Gynecol Reprod Biol; 1984 Jun 15; 17(4):273-84. PubMed ID: 6430731
    [Abstract] [Full Text] [Related]

  • 15. The effects of ovarian wedge resection on circulating gonadotropin and ovarian steroid levels in patients with polycystic ovary syndrome.
    Judd HL, Rigg LA, Anderson DC, Yen SS.
    J Clin Endocrinol Metab; 1976 Aug 15; 43(2):347-55. PubMed ID: 950366
    [Abstract] [Full Text] [Related]

  • 16. Effect of peripheral sex steroid metabolism on pituitary gonadotropin reserve of women with hypothalamic amenorrhea.
    Griffing G, Redline R, Jaffee W, Longcope C, Vaitukaitis J.
    Fertil Steril; 1981 Nov 15; 36(5):578-83. PubMed ID: 6796439
    [Abstract] [Full Text] [Related]

  • 17. The effects of buserelin on the hormonal states in PCOD.
    Willemsen WN, Franssen AM, Rolland R, Vemer HM.
    Prog Clin Biol Res; 1986 Nov 15; 225():377-89. PubMed ID: 3097673
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Adrenal and ovarian steroid hormone responses to gonadotropin-releasing hormone agonist treatment in polycystic ovary syndrome.
    Gonzalez F, Hatala DA, Speroff L.
    Am J Obstet Gynecol; 1991 Sep 15; 165(3):535-45. PubMed ID: 1832519
    [Abstract] [Full Text] [Related]

  • 20. Continuous gonadotropin-releasing hormone for ovulation induction in polycystic ovarian disease.
    Stuckey BG, Keogh EJ, Pullan PT, Beilby JA, Thompson RI, Evans DV.
    Fertil Steril; 1987 Dec 15; 48(6):1055-7. PubMed ID: 3119370
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.